<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">38331459</PMID><DateRevised><Year>2024</Year><Month>03</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1399-3003</ISSN><JournalIssue CitedMedium="Internet"><Volume>63</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>08</Day></PubDate></JournalIssue><Title>The European respiratory journal</Title><ISOAbbreviation>Eur Respir J</ISOAbbreviation></Journal><ArticleTitle>Cluster Analysis to Identify Long COVID Phenotypes Using <sup>129</sup>Xe Magnetic Resonance Imaging: A Multi-centre Evaluation.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2302301</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1183/13993003.02301-2023</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long COVID impacts &#x223c;10% of people diagnosed with COVID-19, yet the pathophysiology driving ongoing symptoms is poorly understood. We hypothesised that <sup>129</sup>Xe magnetic resonance imaging (MRI) could identify unique pulmonary phenotypic subgroups of long COVID, therefore we evaluated ventilation and gas exchange measurements with cluster analysis to generate imaging-based phenotypes.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">COVID-negative controls and participants who previously tested positive for COVID-19 underwent <sup>129</sup>XeMRI &#x223c;14-months post-acute infection across three centres. Long COVID was defined as persistent dyspnea, chest tightness, cough, fatigue, nausea and/or loss of taste/smell at MRI; participants reporting no symptoms were considered fully-recovered. <sup>129</sup>XeMRI ventilation defect percent (VDP) and membrane (Mem)/Gas, red blood cell (RBC)/Mem and RBC/Gas ratios were used in k-means clustering for long COVID, and measurements were compared using ANOVA with post-hoc Bonferroni correction.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We evaluated 135 participants across three centres: 28 COVID-negative (40&#xb1;16yrs), 34 fully-recovered (42&#xb1;14yrs) and 73 long COVID (49&#xb1;13yrs). RBC/Mem (p=0.03) and FEV<sub>1</sub> (p=0.04) were different between long- and COVID-negative; FEV<sub>1</sub> and all other pulmonary function tests (PFTs) were within normal ranges. Four unique long COVID clusters were identified compared with recovered and COVID-negative. Cluster1 was the youngest with normal MRI and mild gas-trapping; Cluster2 was the oldest, characterised by reduced RBC/Mem but normal PFTs; Cluster3 had mildly increased Mem/Gas with normal PFTs; and Cluster4 had markedly increased Mem/Gas with concomitant reduction in RBC/Mem and restrictive PFT pattern.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We identified four <sup>129</sup>XeMRI long COVID phenotypes with distinct characteristics. <sup>129</sup>XeMRI can dissect pathophysiologic heterogeneity of long COVID to enable personalised patient care.</AbstractText><CopyrightInformation>Copyright &#xa9;The authors 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eddy</LastName><ForeName>Rachel L</ForeName><Initials>RL</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mummy</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Radiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shuo</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dai</LastName><ForeName>Haoran</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medical Physics, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bechtel</LastName><ForeName>Aryil</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidt</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frizzell</LastName><ForeName>Bradie</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerayeli</LastName><ForeName>Firoozeh V</ForeName><Initials>FV</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leipsic</LastName><ForeName>Jonathon A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Radiology, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leung</LastName><ForeName>Janice M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Driehuys</LastName><ForeName>Bastiaan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Radiology, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Physics, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Engineering, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Que</LastName><ForeName>Loretta G</ForeName><Initials>LG</Initials><Identifier Source="ORCID">0000-0001-9188-9244</Identifier><AffiliationInfo><Affiliation>Division of Pulmonary, Department of Medicine, Duke University, Durham, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sin</LastName><ForeName>Don D</ForeName><Initials>DD</Initials><AffiliationInfo><Affiliation>Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Respiratory Medicine, Department of Medicine, University of British Columbia, Vancouver, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niedbalski</LastName><ForeName>Peter J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Division of Pulmonary and Critical Care Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA pniedbalski@kumc.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 HL126771</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Respir J</MedlineTA><NlmUniqueID>8803460</NlmUniqueID><ISSNLinking>0903-1936</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Eur Respir J. 2024 Mar 28;63(3):2400381. doi: 10.1183/13993003.00381-2024</RefSource><PMID Version="1">38548274</PMID></CommentsCorrections></CommentsCorrectionsList><CoiStatement>Conflicts of interest: Rachel Eddy reports grants from Michael Smith Health Research BC, Canadian Respiratory Research Network and Natural Sciences and Engineering Research Council Canada, consulting fees from VIDA Diagnostics Inc., payment or honoraria for lectures from Thorasys Thoracic Medical Systems Inc., support for attending meetings and/or travel from Canadian Institutes of Health Research &#x2013; Institute of Circulatory and Respiratory Health, and a leadership or fiduciary role for the Xenon MRI Clinical Trials Consortium (Steering Committee Member). Conflicts of interest: David Mummy reports consultancy fees from Polarean Imaging plc. Conflicts of interest: Firoozeh Gerayeli reports grants from MITACS Accelerate. Conflicts of interest: Jonathon Leipsic reports grants from GE Healthcare, consultancy fees and support for attending meetings and/or travel from Heartflow, and owns stock/stock options in Heartflow. Conflicts of interest: Janice Leung reports grants from Canadian Institutes of Health Research and BC Lung Foundation, payment or honoraria for lectures, presentations, manuscript writing or educational events from BC Lung Foundation, participation on a data safety monitoring board or advisory board for Enhance Quality Safety, and Patient experience in Chronic Obstructive Pulmonary Disorder (EQuiP COPD), and leadership or fiduciary roles for Canadian Respiratory Research Network and CanCOLD Study. Conflicts of interest: Bastiaan Driehuys reports grants from Translating Duke Health (Duke Internal Award), royalties or licenses from Polarean Imaging, a leadership or fiduciary role with Polarean Imaging, and owns stock/stock options in Polarean Imaging. Conflicts of interest: Loretta G. Que reports grants from Translating Duke Health (Duke Internal Award), and a leadership or fiduciary role as member of XeMRI Consortium. Conflicts of interest: Mario Castro reports grants from NIH, ALA, PCORI, AstraZeneca, Gala Therapeutics, Genentech, GSK, Novartis, Pulmatrix, Sanofi-Aventis, Shionogi and Theravance, consulting fees from Genentech, Teva, Sanofi-Aventis, Merck, Novartis, Arrowhead Pharmaceuticals, Allakos, Amgen, OM Pharma, Pfizer, Pioneering Medicines and GSK, payment or honoraria for lectures, presentations, manuscript writing or educational events from Amgen, AstraZeneca, Genentech, Regeneron, Sanofi-Aventis and Teva, and owns stock/stock options in Aer Therapeutics. Conflicts of interest: Don D. Sin reports payment or honoraria for lectures, presentations, manuscript writing or educational events from GSK, AZ and BI, and participation on a data safety monitoring board or advisory board for NHLBI. Conflicts of interest: Peter Niedbalski reports grants from Scleroderma Foundation (new investigator grant) and American Heart Association (CDA 930177), and consultancy fees, payment or honoraria for lectures, and support for attending meetings and/or travel from Polarean Imaging Plc. Conflicts of interest: The remaining authors have no potential conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>8</Day><Hour>20</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38331459</ArticleId><ArticleId IdType="pmc">PMC10973687</ArticleId><ArticleId IdType="doi">10.1183/13993003.02301-2023</ArticleId><ArticleId IdType="pii">13993003.02301-2023</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence . COVID-19 rapid guideline: managing the long-term effects of COVID-19. 2020. www.nice.org.uk/guidance/ng188
Date last accessed: 2 February 2024.</Citation></Reference><Reference><Citation>US Centers for Disease Control and Prevention . Long COVID or post-COVID conditions. 2023. www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html
Date last accessed: 4 September 2023.</Citation></Reference><Reference><Citation>World Health Organisation . A clinical case definition of post COVID-19 condition by a Delphi consensus. 2021. www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
Date last accessed: 2 February 2024.</Citation></Reference><Reference><Citation>Global Burden of Disease Long COVID Collaborators . Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA 2022; 328: 1604&#x2013;1615. doi:10.1001/jama.2022.18931</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2022.18931</ArticleId><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, et al. . Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis 2022; 226: 1593&#x2013;1607. doi:10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, McCorkell L, Vogel JM, et al. . Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 2023; 21: 133&#x2013;146. doi:10.1038/s41579-022-00846-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford ND, Slaughter D, Edwards D, et al. . Long COVID and significant activity limitation among adults, by age &#x2013; United States, June 1&#x2013;13, 2022, to June 7&#x2013;19, 2023. MMWR Morb Mortal Wkly Rep 2023; 72: 866&#x2013;870. doi:10.15585/mmwr.mm7232a3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7232a3</ArticleId><ArticleId IdType="pmc">PMC10415000</ArticleId><ArticleId IdType="pubmed">37561665</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2&#x2005;years. Nat Med 2023; 29: 2347&#x2013;2357. doi:10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open 2022; 5: e2238804. doi:10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho JL, Villacreses R, Nagpal P, et al. . Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology 2022; 304: 185&#x2013;192. doi:10.1148/radiol.212170</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212170</ArticleId><ArticleId IdType="pmc">PMC9270680</ArticleId><ArticleId IdType="pubmed">35289657</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooner HK, McIntosh MJ, Matheson AM, et al. . 129Xe MRI ventilation defects in ever-hospitalised and never-hospitalised people with post-acute COVID-19 syndrome. BMJ Open Respir Res 2022; 9: e001235. doi:10.1136/bmjresp-2022-001235</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2022-001235</ArticleId><ArticleId IdType="pmc">PMC9119175</ArticleId><ArticleId IdType="pubmed">35584850</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooner HK, McIntosh MJ, Matheson AM, et al. . Post-acute COVID-19 syndrome: 129Xe MRI ventilation defects and respiratory outcomes one year later. Radiology 2023; 307: e222557. doi:10.1148/radiol.222557</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.222557</ArticleId><ArticleId IdType="pmc">PMC9926501</ArticleId><ArticleId IdType="pubmed">36749209</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Chen M, Collier GJ, et al. . Hyperpolarized 129Xe MRI abnormalities in dyspneic patients 3&#x2005;months after COVID-19 pneumonia: preliminary results. Radiology 2021; 301: E353&#x2013;E360. doi:10.1148/radiol.2021210033</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021210033</ArticleId><ArticleId IdType="pmc">PMC8168952</ArticleId><ArticleId IdType="pubmed">34032513</ArticleId></ArticleIdList></Reference><Reference><Citation>Grist JT, Collier GJ, Walters H, et al. . Lung abnormalities depicted with hyperpolarized xenon MRI in patients with long COVID. Radiology 2022; 305: 709&#x2013;717. doi:10.1148/radiol.220069</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220069</ArticleId><ArticleId IdType="pmc">PMC9134268</ArticleId><ArticleId IdType="pubmed">35608443</ArticleId></ArticleIdList></Reference><Reference><Citation>Saunders LC, Collier GJ, Chan HF, et al. . Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI. Chest 2023; 164: 700&#x2013;716. doi:10.1016/j.chest.2023.03.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2023.03.024</ArticleId><ArticleId IdType="pmc">PMC10036146</ArticleId><ArticleId IdType="pubmed">36965765</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson AM, McIntosh MJ, Kooner HK, et al. . Persistent 129Xe MRI pulmonary and CT vascular abnormalities in symptomatic individuals with post-acute COVID-19 syndrome. Radiology 2022; 305: 466&#x2013;476. doi:10.1148/radiol.220492</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.220492</ArticleId><ArticleId IdType="pmc">PMC9272782</ArticleId><ArticleId IdType="pubmed">35762891</ArticleId></ArticleIdList></Reference><Reference><Citation>Matheson AM, McIntosh MJ, Kooner HK, et al. . Longitudinal follow-up of postacute COVID-19 syndrome: DLCO, quality-of-life and MRI pulmonary gas-exchange abnormalities. Thorax 2023; 78: 418&#x2013;421. doi:10.1136/thorax-2022-219378</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thorax-2022-219378</ArticleId><ArticleId IdType="pmc">PMC10086459</ArticleId><ArticleId IdType="pubmed">36596692</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. . Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med 2020; 383: 120&#x2013;128. doi:10.1056/NEJMoa2015432</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2015432</ArticleId><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, et al. . Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med 2022; 28: 1706&#x2013;1714. doi:10.1038/s41591-022-01909-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Zang C, Xu Z, et al. . Data-driven identification of post-acute SARS-CoV-2 infection subphenotypes. Nat Med 2023; 29: 226&#x2013;235. doi:10.1038/s41591-022-02116-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02116-3</ArticleId><ArticleId IdType="pmc">PMC9873564</ArticleId><ArticleId IdType="pubmed">36456834</ArticleId></ArticleIdList></Reference><Reference><Citation>Danesh V, Arroliga AC, Bourgeois JA, et al. . Symptom clusters seen in adult COVID-19 recovery clinic care seekers. J Gen Intern Med 2023; 38: 442&#x2013;449. doi:10.1007/s11606-022-07908-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-022-07908-4</ArticleId><ArticleId IdType="pmc">PMC9663188</ArticleId><ArticleId IdType="pubmed">36376627</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi S, Hoffman EA, Wenzel SE, et al. . Quantitative computed tomographic imaging-based clustering differentiates asthmatic subgroups with distinctive clinical phenotypes. J Allergy Clin Immunol 2017; 140: 690&#x2013;700. doi:10.1016/j.jaci.2016.11.053</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.11.053</ArticleId><ArticleId IdType="pmc">PMC5534190</ArticleId><ArticleId IdType="pubmed">28143694</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy RL, McIntosh MJ, Matheson AM, et al. . Pulmonary MRI and cluster analysis help identify novel asthma phenotypes. J Magn Reson Imaging 2022; 56: 1475&#x2013;1486. doi:10.1002/jmri.28152</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmri.28152</ArticleId><ArticleId IdType="pubmed">35278011</ArticleId></ArticleIdList></Reference><Reference><Citation>Billatos E, Ash SY, Duan F, et al. . Distinguishing smoking-related lung disease phenotypes via imaging and molecular features. Chest 2021; 159: 549&#x2013;563. doi:10.1016/j.chest.2020.08.2115</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.08.2115</ArticleId><ArticleId IdType="pmc">PMC8039011</ArticleId><ArticleId IdType="pubmed">32946850</ArticleId></ArticleIdList></Reference><Reference><Citation>Eddy RL, Mummy D, Dai H, et al. . 129Xe magnetic resonance imaging-based phenotypes of long COVID: a multi-center evaluation. Am J Respir Crit Care Med 2023; 207: A6786. doi:10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6786</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm-conference.2023.207.1_MeetingAbstracts.A6786</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: Suppl. B, 25&#x2013;31. doi:10.1016/S0954-6111(06)80166-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0954-6111(06)80166-6</ArticleId><ArticleId IdType="pubmed">1759018</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller MR, Hankinson J, Brusasco V, et al. . Standardisation of spirometry. Eur Respir J 2005; 26: 319&#x2013;338. doi:10.1183/09031936.05.00034805</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00034805</ArticleId><ArticleId IdType="pubmed">16055882</ArticleId></ArticleIdList></Reference><Reference><Citation>Wanger J, Clausen JL, Coates A, et al. . Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511&#x2013;522. doi:10.1183/09031936.05.00035005</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.05.00035005</ArticleId><ArticleId IdType="pubmed">16135736</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham BL, Brusasco V, Burgos F, et al. . 2017 ERS/ATS standards for single-breath carbon monoxide uptake in the lung. Eur Respir J 2017; 49: 1600016. doi:10.1183/13993003.00016-2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00016-2016</ArticleId><ArticleId IdType="pubmed">28049168</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman C, Bhakta NR, Brazzale D, et al. . A race-neutral approach to the interpretation of lung function measurements. Am J Respir Crit Care Med 2023; 207: 768&#x2013;774. doi:10.1164/rccm.202205-0963OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202205-0963OC</ArticleId><ArticleId IdType="pubmed">36383197</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedbalski PJ, Hall CS, Castro M, et al. . Protocols for multi-site trials using hyperpolarized 129Xe MRI for imaging of ventilation, alveolar-airspace size, and gas exchange: a position paper from the 129Xe MRI Clinical Trials Consortium. Magn Reson Med 2021; 86: 2966&#x2013;2986. doi:10.1002/mrm.28985</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28985</ArticleId><ArticleId IdType="pubmed">34478584</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedbalski PJ, Willmering MM, Thomen RP, et al. . A single-breath-hold protocol for hyperpolarized 129Xe ventilation and gas exchange imaging. NMR Biomed 2023; 36: e4923. doi:10.1002/nbm.4923</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.4923</ArticleId><ArticleId IdType="pmc">PMC11077533</ArticleId><ArticleId IdType="pubmed">36914278</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedbalski PJ, Lu J, Hall CS, et al. . Utilizing flip angle/TR equivalence to reduce breath hold duration in hyperpolarized 129Xe 1-point Dixon gas exchange imaging. Magn Reson Med 2022; 87: 1490&#x2013;1499. doi:10.1002/mrm.29040</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.29040</ArticleId><ArticleId IdType="pmc">PMC8776583</ArticleId><ArticleId IdType="pubmed">34644815</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Robertson SH, Wang J, et al. . Quantitative analysis of hyperpolarized 129Xe gas transfer MRI. Med Phys 2017; 44: 2415&#x2013;2428. doi:10.1002/mp.12264</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mp.12264</ArticleId><ArticleId IdType="pubmed">28382694</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Zhao X, Wang Y, et al. . Damaged lung gas exchange function of discharged COVID-19 patients detected by hyperpolarized 129Xe MRI. Sci Adv 2021; 7: eabc8180. doi:10.1126/sciadv.abc8180</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abc8180</ArticleId><ArticleId IdType="pmc">PMC7775756</ArticleId><ArticleId IdType="pubmed">33219111</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. . Endothelial cell infection and endotheliitis in COVID-19. Lancet 2020; 395: 1417&#x2013;1418. doi:10.1016/S0140-6736(20)30937-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart I, Jacob J, George PM, et al. . Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post-COVID-19 study. Am J Respir Crit Care Med 2023; 207: 693&#x2013;703. doi:10.1164/rccm.202203-0564OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202203-0564OC</ArticleId><ArticleId IdType="pmc">PMC10037479</ArticleId><ArticleId IdType="pubmed">36457159</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Bier EA, Swaminathan A, et al. . Diverse cardiopulmonary diseases are associated with distinct xenon magnetic resonance imaging signatures. Eur Respir J 2019; 54: 1900831. doi: 10.1183/13993003.00831-2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00831-2019</ArticleId><ArticleId IdType="pmc">PMC7271066</ArticleId><ArticleId IdType="pubmed">31619473</ArticleId></ArticleIdList></Reference><Reference><Citation>Collier GJ, Eaden JA, Hughes PJC, et al. . Dissolved 129Xe lung MRI with four-echo 3D radial spectroscopic imaging: quantification of regional gas transfer in idiopathic pulmonary fibrosis. Magn Reson Med 2021; 85: 2622&#x2013;2633. doi:10.1002/mrm.28609</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mrm.28609</ArticleId><ArticleId IdType="pubmed">33252157</ArticleId></ArticleIdList></Reference><Reference><Citation>Mummy DG, Bier EA, Wang Z, et al. . Hyperpolarized 129Xe MRI and spectroscopy of gas-exchange abnormalities in nonspecific interstitial pneumonia. Radiology 2021; 301: 211&#x2013;220. doi:10.1148/radiol.2021204149</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021204149</ArticleId><ArticleId IdType="pmc">PMC8487218</ArticleId><ArticleId IdType="pubmed">34313473</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>